Open AccessAre All ß Blockers the Same for Heart Failure?
Author(s) -
Kukin Marrick L.
Publication year - 2000
Publication title -
congestive heart failure
Language(s) - English
Resource type - Journals
eISSN - 1751-7133
pISSN - 1527-5299
DOI - 10.1111/j.1527-5299.2000.80149.x
Subject(s) - medicine , heart failure , beta (programming language) , intensive care medicine , clinical trial , cardiology , computer science , programming language
Based on impressive morbidity and mortality data using β blockers in heart failure, this therapy has now become part of the standard of care for patients with New York Heart Association II/III symptoms. The question remains whether there are clinically relevant differences between the β blockers that have shown beneficial effects. This review summarizes the major mortality trials, and examines the smaller comparative trials of second and third generation β blockers.